According to Roche's latest financial reports the company's current revenue (TTM) is $71.88 B. In 2023 the company made a revenue of $71.88 B an increase over the years 2022 revenue that were of $71.24 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 | $71.88 B | 0.91% |
2022 | $71.24 B | 3.65% |
2021 | $68.73 B | 3.89% |
2020 | $66.15 B | 4.26% |
2019 | $63.45 B | 9.8% |
2018 | $57.79 B | 5.58% |
2017 | $54.73 B | 10.25% |
2016 | $49.64 B | 1.88% |
2015 | $48.72 B | 1.49% |
2014 | $48.01 B | -8.94% |
2013 | $52.72 B | 5.76% |
2012 | $49.85 B | 9.97% |
2011 | $45.33 B | -10.75% |
2010 | $50.80 B | 7.11% |
2009 | $47.42 B | 8.43% |
2008 | $43.74 B | 7.33% |
2007 | $40.75 B | 17.93% |
2006 | $34.55 B | 28.04% |
2005 | $26.98 B | 4.26% |
2004 | $25.88 B | 2.53% |
2003 | $25.24 B | -21.78% |
2002 | $32.27 B | 0.99% |
2001 | $31.95 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $89.65 B | 24.72% | ๐บ๐ธ USA |
Novartis NVS | $49.92 B | -30.55% | ๐จ๐ญ Switzerland |
Pfizer PFE | $58.49 B | -18.63% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $40.10 B | -44.21% | ๐บ๐ธ USA |
Amgen AMGN | $28.19 B | -60.79% | ๐บ๐ธ USA |
Sanofi SNY | $50.51 B | -29.73% | ๐ซ๐ท France |
Becton Dickinson BDX | $19.49 B | -72.89% | ๐บ๐ธ USA |
Merck MRK | $60.11 B | -16.38% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $38.54 B | -46.38% | ๐ฌ๐ง UK |